TABLE 1

Baseline and clinical characteristics of invasively ventilated COVID-19 survivors (n=50)

Baseline characteristics
 Age years61 (52–68)
 Sex, male26 (52)
 BMI kg·m−228 (27–34)
 BMI group
  Normal (18.5–24.9 kg·m−2)5 (10)
  Overweight (25–29.9 kg·m−2)26 (52)
  Obese (>30 kg·m−2)19 (38)
 Comorbidities
  Hypertension21 (42)
  Dyslipidaemia14 (28)
  Diabetes mellitus12 (24)
  COPD4 (8)
  Asthma3 (6)
  Active malignancy3 (6)
  SAHS3 (6)
  Ischaemic heart disease1 (2)
  Chronic renal disease1 (2)
 Smoking history
  Never33 (66)
  Former10 (20)
  Current2 (4)
  Unknown5 (10)
 Charlson Comorbidity Index2 (1–4)
Clinical characteristics
 SOFA6.5 (4.5–7)
 Invasive mechanical ventilation days11 (8–22)
 Prolonged mechanical ventilation (≥21 days)13 (26)
 Tracheostomy11 (22)
 Re-intubation6 (12)
 Pulmonary thromboembolism9 (18)
 Continuous neuromuscular blockade46 (92)
 Systemic corticosteroids during admission#50 (100)
 Length of stay in ICU days15 (12–29)
 Length of stay post-ICU days7.5 (6–13)
 Length of stay in hospital days27.5 (23–45)
 Supplemental O2
  Hospital discharge27 (54)
  3 months follow-up visit3 (6)
  6 months follow-up visit2 (4)
 Hospital discharge destination
  Home20 (40)
  Home with follow-up physiotherapy15 (30)
  Inpatient rehabilitation13 (26)
  Home with outpatient physiotherapy2 (4)

Data are presented as median (25th–75th percentile) for continuous variables and n (%) for categorical variables. BMI: body mass index; SAHS: sleep apnoea–hypopnoea syndrome; SOFA: sequential organ failure assessment; ICU: intensive care unit. #: course of intravenous dexamethasone.